YEAR
- 2014.06.05 Non-diethylstilbestrol exposed vaginal clear cell adenocarcinoma has a common molecular profile with ovarian clear cell adenocarcinoma: A case report. Ikeda Y, Oda K, Aburatani H, Kawana K, Osuga Y, Fujii T.Gynecol Oncol Rep. 2014 Dec;10:49-52. doi: 10.1016/j.gynor.2014.05.006
- 2014.06.01 A (90)Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy. Fujiwara K, Koyama K, Suga K, Ikemura M, Saito Y, Hino A, Iwanari H, Kusano-Arai O, Mitsui K, Kasahara H, Fukayama M, Kodama T, Hamakubo T, Momose T.EJNMMI Res. 2014;4:29. doi: 10.1186/s13550-014-0029-3
- 2014.05.24 Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients. Takane K, Midorikawa Y, Yagi K, Sakai A, Aburatani H, Takayama T, Kaneda A.Cancer Med. 2014 Oct;3(5):1235-45. doi: 10.1002/cam4.273
- 2014.05.13 Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells. Nakahara F, Kitaura J, Uchida T, Nishida C, Togami K, Inoue D, Matsukawa T, Kagiyama Y, Enomoto Y, Kawabata KC, Chen-Yi L, Komeno Y, Izawa K, Oki T, Nagae G, Harada Y, Harada H, Otsu M, Aburatani H, Heissig B, Hattori K, Kitamura T.Blood. 2014 Jun 19;123(25):3932-42. doi: 10.1182/blood-2013-01-476747
- 2014.05.11 Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, Yamamoto S, Tatsuno K, Katoh H, Watanabe Y, Ichimura T, Ushiku T, Funahashi S, Tateishi K, Wada I, Shimizu N, Nomura S, Koike K, Seto Y, Fukayama M, Aburatani H, Ishikawa S.Nat. Genet. 2014 Jun;46(6):583-7. doi: 10.1038/ng.2984
- 2014.05.05 Direct evidence for pitavastatin induced chromatin structure change in the KLF4 gene in endothelial cells. Maejima T, Inoue T, Kanki Y, Kohro T, Li G, Ohta Y, Kimura H, Kobayashi M, Taguchi A, Tsutsumi S, Iwanari H, Yamamoto S, Aruga H, Dong S, Stevens JF, Poh HM, Yamamoto K, Kawamura T, Mimura I, Suehiro J, Sugiyama A, Kaneki K, Shibata H, Yoshinaka Y, Doi T, Asanuma A, Tanabe S, Tanaka T, Minami T, Hamakubo T, Sakai J, Nozaki N, Aburatani H, Nangaku M, Ruan X, Tanabe H, Ruan Y, Ihara S, Endo A, Kodama T, Wada Y.PLoS ONE. 2014;9(5):e96005. doi: 10.1371/journal.pone.0096005
- 2014.05.02 Multilayer-omics analysis of renal cell carcinoma, including the whole exome, methylome and transcriptome. Arai E, Sakamoto H, Ichikawa H, Totsuka H, Chiku S, Gotoh M, Mori T, Nakatani T, Ohnami S, Nakagawa T, Fujimoto H, Wang L, Aburatani H, Yoshida T, Kanai Y.Int. J. Cancer. 2014 Sep 15;135(6):1330-42. doi: 10.1002/ijc.28768
- 2014.04.29 ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models. Parray A, Siddique HR, Kuriger JK, Mishra SK, Rhim JS, Nelson HH, Aburatani H, Konety BR, Koochekpour S, Saleem M.Int. J. Cancer. 2014 Dec 01;135(11):2493-506. doi: 10.1002/ijc.28919
CLOSE